HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Altering APP proteolysis: increasing sAPPalpha production by targeting dimerization of the APP ectodomain.

Abstract
One of the events associated with Alzheimer's disease is the dysregulation of α- versus β-cleavage of the amyloid precursor protein (APP). The product of α-cleavage (sAPPα) has neuroprotective properties, while Aβ1-42 peptide, a product of β-cleavage, is neurotoxic. Dimerization of APP has been shown to influence the relative rate of α- and β- cleavage of APP. Thus finding compounds that interfere with dimerization of the APP ectodomain and increase the α-cleavage of APP could lead to the development of new therapies for Alzheimer's disease. Examining the intrinsic fluorescence of a fragment of the ectodomain of APP, which dimerizes through the E2 and Aβ-cognate domains, revealed significant changes in the fluorescence of the fragment upon binding of Aβ oligomers--which bind to dimers of the ectodomain--and Aβ fragments--which destabilize dimers of the ectodomain. This technique was extended to show that RERMS-containing peptides (APP(695) 328-332), disulfiram, and sulfiram also inhibit dimerization of the ectodomain fragment. This activity was confirmed with small angle x-ray scattering. Analysis of the activity of disulfiram and sulfiram in an AlphaLISA assay indicated that both compounds significantly enhance the production of sAPPα by 7W-CHO and B103 neuroblastoma cells. These observations demonstrate that there is a class of compounds that modulates the conformation of the APP ectodomain and influences the ratio of α- to β-cleavage of APP. These compounds provide a rationale for the development of a new class of therapeutics for Alzheimer's disease.
AuthorsClare A Peters Libeu, Olivier Descamps, Qiang Zhang, Varghese John, Dale E Bredesen
JournalPloS one (PLoS One) Vol. 7 Issue 6 Pg. e40027 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID22768208 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • APP protein, human
  • Amyloid beta-Protein Precursor
  • Anilino Naphthalenesulfonates
  • Peptide Fragments
  • Peptides
  • Recombinant Fusion Proteins
  • monosulfiram
  • 1-anilino-8-naphthalenesulfonate
  • Tryptophan
  • Disulfiram
Topics
  • Amyloid beta-Protein Precursor (biosynthesis, chemistry)
  • Anilino Naphthalenesulfonates (metabolism)
  • Animals
  • CHO Cells
  • Cricetinae
  • Disulfiram (analogs & derivatives, metabolism)
  • Fluorescence
  • Humans
  • Models, Molecular
  • Peptide Fragments (biosynthesis, chemistry)
  • Peptides (metabolism)
  • Protein Binding
  • Protein Multimerization
  • Protein Structure, Tertiary
  • Proteolysis
  • Rats
  • Recombinant Fusion Proteins (metabolism)
  • Scattering, Small Angle
  • Tryptophan (metabolism)
  • X-Ray Diffraction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: